Phenobarbital Injection Shortage
Last Updated: November 15, 2022
Status: Current
Reason for the Shortage
-
- Hikma did not provide a reason for the shortage.
- BPI launched phenobarbital injection (alcohol-free) in May 2022.
Available Products
-
- Phenobarbital sodium intravenous injection, BPI Labs, 130 mg/mL, 1 mL vial, 10 count, NDC 54288-0137-10
- Phenobarbital sodium intravenous injection, BPI Labs, 65 mg/mL, 1 mL vial, 10 count, NDC 54288-0136-10
- Phenobarbital sodium intravenous injection, Hikma, 130 mg/mL, 1 mL vial, 25 count, NDC 00641-0477-25
- Phenobarbital sodium intravenous injection, Hikma, 65 mg/mL, 1 mL vial, 25 count, NDC 00641-0476-25
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated November 15, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 8, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.